Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 8761
TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397126(US9987259, Example 19 | N-[(3S)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397141(US9987259, Example 46 | US10456385, Example 46)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397140(US9987259, Example 45 | (1-azabicyclo[2.2.2]octan-...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397139(US9987259, Example 42 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397138(US9987259, Example 33 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397137(US9987259, Example 30 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397136(US9987259, Example 29 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397135(US9987259, Example 28 | N-[(3S)-1-azabicyclo[2.2.2...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397134(US9987259, Example 27 | N-[(3R)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397133(US9987259, Example 26 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397132(US9987259, Example 25 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397131(US9987259, Example 24 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397130(US9987259, Example 23 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397129(US9987259, Example 22 | N-[(3S)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397128(US9987259, Example 21 | N-[(3R)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397127(US9987259, Example 20 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397111(US9987259, Example 1 | N-(1-azabicyclo[2.2.2]octan...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397125(US9987259, Example 18 | N-[(3R)-1-azabicyclo[2.2.2...)
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397124(US9987259, Example 17 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397123(US9987259, Example 16 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397122(US9987259, Example 15 | N-[(3S)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397121(US9987259, Example 14 | N-[(3R)-1-azabicyclo[2.2.2...)
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397120(US9987259, Example 13 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397119(US9987259, Example 12 | N-[(3S)-1-azabicyclo[2.2.2...)
Affinity DataEC50:  750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397118(US9987259, Example 11 | N-[(3R)-1-azabicyclo[2.2.2...)
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397117(US9987259, Example 10 | N-(1-azabicyclo[2.2.2]octa...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397116(US9987259, Example 9 | N-(1-azabicyclo[2.2.2]octan...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397115(US9987259, Example 7 | N-(1-azabicyclo[2.2.2]octan...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397114(US9987259, Example 6 | N-(1-azabicyclo[2.2.2]octan...)
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397113(US9987259, Example 3 | N-[(3S)-1-azabicyclo[2.2.2]...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Human)
Sk Biopharmaceuticals

US Patent
LigandPNGBDBM397112(US9987259, Example 2 | N-[(3R)-1-azabicyclo[2.2.2]...)
Affinity DataEC50:  300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
Go to US Patent